Tag: antiviral

Sosei Heptares’ COVID-19 programme advances promising molecules

by Lucy Parsons | Nov 20, 2020 | News | 0

R&D programme is focused on developing small molecules against SARS-CoV-2 virus

Gilead to start testing an inhaled form of remdesivir

by Selina McKee | Jun 23, 2020 | News | 0

The firm is targeting an earlier stage in the treatment pathway for COVID-19

MSD unveils bid to tackle coronavirus pandemic

by Selina McKee | May 27, 2020 | News | 0

The group will work on two experimental vaccines and an antiviral

US approves first-in-class flu drug

by Selina McKee | Oct 29, 2018 | News | 0

The US Food and Drug Administration has approved Roche/Shionogi & Co’s Xofluza for the treatment of acute uncomplicated flu, opening the door to the first new antiviral with a novel mechanism of action in nearly 20 years.

Merck gears up to file antiviral letermovir in the US, EU

by Selina McKee | Feb 27, 2017 | News | 0

Merck & Co said it is planning to submit regulatory applications for letermovir in the US and European Union sometime this year, on the back of late-stage data showing its promise in preventing a serious viral infection in patients undergoing a bone marrow transplant.